Bristol Myers Squibb Completes Sale of Manufacturing Facility in Couvet, Switzerland Biotech Investing
Bausch Health Announces Plans To Pursue An Initial Public Offering Of Solta Medical Medical Device Investing
Lp HORIZON achieves 50% enrollment in trial to assess the safety and efficacy of pelacarsen in reducing recurrent cardiovascular events Pharmaceutical Investing
Abbott's FreeStyle® Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management Medical Device Investing
Bristol Myers Squibb Receives European Commission Approval for Opdivo as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy Biotech Investing
Numinus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into Psychedelic Neurology Cannabis Investing News
Merck Announces Appointment of Cristal N. Downing as Chief Communications & Public Affairs Officer Pharmaceutical Investing
